Log in

CVE:WEYLexagene Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
LexaGene Holdings Inc, formerly Wolfeye Resource Corp, is a Canada-based biotechnology company. The Company focuses on building automated instruments for rapid pathogen detection. The Company's instrument operates a layperson, allowing the Company to place these instruments at the site of collection, whether inside of food processing plants or inside hospitals.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.40 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+1-604-6810084

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive WEY News and Ratings via Email

Sign-up to receive the latest news and ratings for WEY and its competitors with MarketBeat's FREE daily newsletter.

Lexagene (CVE:WEY) Frequently Asked Questions

Has Lexagene been receiving favorable news coverage?

Media stories about WEY stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Lexagene earned a coverage optimism score of -1.1 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutLexagene.

Who are Lexagene's key executives?

Lexagene's management team includes the following people:
  • John F Regan, Chairman of the Board, Chief Executive Officer
  • Daryl Rebeck, President, Director
  • Jeffrey Mitchell, Chief Financial Officer
  • Greg Dale, Vice President - Product Development and Manufacturing
  • Allan J. Fabbro, Vice President - Corporate Development
  • Manohar Rajeev Furtado Ph.D., Director
  • Jim Hutchens, Director
  • Tom Slezak, Director

What is Lexagene's stock symbol?

Lexagene trades on the Canadian Venture Exchange (CVE) under the ticker symbol "WEY."

How do I buy shares of Lexagene?

Shares of WEY and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Lexagene's official website?

The official website for Lexagene is lexagene.com.

How can I contact Lexagene?

Lexagene's mailing address is 750 Pender St W Suite 303, VANCOUVER, BC V6C 2T7, Canada. The company can be reached via phone at +1-604-6810084.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.